Ebola: To Parse, Perchance to Parlay[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
Articles
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Thanks, @@Travis (@@admin) for this meticulous analysis (as always). VLDR is the stock in all likelihood, but I am littl...
Spectral Medical {EDT on TSX] is way ahead of CTSO and has better outcomes with their proprietary system. They have bee...
CTSO has nothing proven. They are years away from proving what they hope and 'cytokine storm' is a made up word. If you ...
Also, you might want to check out the news about Cytosorbents, CTSO. They manufacture a cartridge that fits into standa...
Any gumshoe insight on these 2 companies lately? Seems like both have been making progress. AEMD flew out a hemopurifi...
A few days ago, I was thinking to myself: I have heard no recent shill for Cytosorbents (CTSO), the dubious penny stock ...
To James Fernow: not so sure about Alder, after all. Their trials of their monoclonal against calcitonin gene related pe...
Herbalix: Thanks for the links. I had come across those in researching CytoSorbents (CTSO). In my view, what those items...